This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Jonathan W. Friedberg, is devoted to Follicular Lymphoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Articles in this important issue include: Epidemiology of Follicular Lymphoma, Pathogenesis of Follicular Lymphoma, Circulating tumor DNA and MRD assessment in Follicular Lymphoma, Clinical and biological prognostic factors in Follicular Lymphoma, Vitamin D and Follicular Lymphoma, Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma, Initial Treatment of High Tumor Burden Follicular Lymphoma, Maintenance Antibody Therapy of Follicular Lymphoma, Cellular Therapy in Follicular Lymphoma, Immunomodulatory Agents in Follicular Lymphoma, Phosphoinositide 3-Kinase Inhibition in Follicular Lymphoma, Novel Agents Beyond Immunomodulatory Imide Drugs and Phosphoinositide 3-Kinases for Follicular Lymphoma, Early progression of Follicular Lymphoma, Biological Basis of Histological Transformation, and Treatment of Histological Transformation.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Hematology/Oncology Clinics of North America - p. xi 7. Preface - p. xiii 8. Epidemiology of Follicular Lymphoma - p. 631 9. Clinical and Biological Prognostic Factors in Follicular Lymphoma - p. 647 10. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma - p. 663 11. Initial Treatment of High Tumor Burden Follicular Lymphoma - p. 673 12. Antibody Therapy Maintenance in Follicular Lymphoma - p. 689 13. Cellular Therapy in Follicular Lymphoma: Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, and Chimeric Antigen Receptor T-cell Therapy - p. 701 14. Immunomodulatory Agents in Follicular Lymphoma - p. 715 15. Phosphatidylinositol-3-Kinase Inhibition in Follicular Lymphoma - p. 727 16. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma - p. 743 17. Early Progression of Follicular Lymphoma: Biology and Treatment - p. 757 18. The Biological Basis of Histologic Transformation - p. 771 19. Treatment of Histologic Transformation - p. 785
This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Jonathan W. Friedberg, is devoted to Follicular Lymphoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Articles in this important issue include: Epidemiology of Follicular Lymphoma, Pathogenesis of Follicular Lymphoma, Circulating tumor DNA and MRD assessment in Follicular Lymphoma, Clinical and biological prognostic factors in Follicular Lymphoma, Vitamin D and Follicular Lymphoma, Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma, Initial Treatment of High Tumor Burden Follicular Lymphoma, Maintenance Antibody Therapy of Follicular Lymphoma, Cellular Therapy in Follicular Lymphoma, Immunomodulatory Agents in Follicular Lymphoma, Phosphoinositide 3-Kinase Inhibition in Follicular Lymphoma, Novel Agents Beyond Immunomodulatory Imide Drugs and Phosphoinositide 3-Kinases for Follicular Lymphoma, Early progression of Follicular Lymphoma, Biological Basis of Histological Transformation, and Treatment of Histological Transformation.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Hematology/Oncology Clinics of North America - p. xi 7. Preface - p. xiii 8. Epidemiology of Follicular Lymphoma - p. 631 9. Clinical and Biological Prognostic Factors in Follicular Lymphoma - p. 647 10. Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma - p. 663 11. Initial Treatment of High Tumor Burden Follicular Lymphoma - p. 673 12. Antibody Therapy Maintenance in Follicular Lymphoma - p. 689 13. Cellular Therapy in Follicular Lymphoma: Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, and Chimeric Antigen Receptor T-cell Therapy - p. 701 14. Immunomodulatory Agents in Follicular Lymphoma - p. 715 15. Phosphatidylinositol-3-Kinase Inhibition in Follicular Lymphoma - p. 727 16. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma - p. 743 17. Early Progression of Follicular Lymphoma: Biology and Treatment - p. 757 18. The Biological Basis of Histologic Transformation - p. 771 19. Treatment of Histologic Transformation - p. 785
